A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
Clinical trial NCT01469039 · COMPLETED
Trial details
- NCT number
- NCT01469039
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-01-01
- Enrollment
- 623
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.